viernes, 11 de noviembre de 2011

FOR THE HEALTH OF THE PEOPLE: NEW CLINICAL TRIAL IN THE HOSPITAL RIGHT MANZANILLO Celia Sanchez.


By Rodrigo Tamayo  Motas
------------------------------------
Thanks to the enormous task of a medical team of the provincial hospital surgical clinic teacher Celia Sanchez, Manzanillo, from Thursday November 10 will begin implementing a new clinical trial aimed at combating acute hemorrhoidal disease.

Four Named TERESA, materializes after obtaining excellent results among institutions of its kind in the country TERESA treatments two and three, noted in this space the degree Milanés War Bedi, head of the department of clinical trials in the health institution Manzanillo.

This acute hemorrhoidal disease treatment involves the use of streptokinase and ANSOL suppository in the pathology of fluxion and thrombosed hemorrhoid. Streptokinase is an extracellular enzyme produced by beta hemolytic streptococcus, used as an effective and inexpensive drug that dissolves blood clots.

Although medical treatment research with vaccines and other preventive and not curative, enables the patient to substantially improve their quality of life.

Among the clinical trials in hospital unquestionable results Celia include application of the EGF vaccine for people with lung cancer and treatment for women with breast tumor metastatic stage.

The health unit is a Cuban institution that uses this procedure to prolong the existence of those suffering from the disease.
                                                                                                             
Currently in the hospital Celia Sanchez, Manzanillo, develop 14 studies among which prostate, lung, breast, and head - neck, emphasizing a recognition by the Center for Genetic Engineering and Biotechnology and a second place nationally by the inclusion of patients.

No hay comentarios: